EUVIMEDEUVIMED entdecken
Open Access

Prospective operational feasibility, safety, and workflow of magnetic resonance-guided tracking technology for interstitial gynecologic brachytherapy

Michael Roumeliotis, Majd Antaki, Gayoung Kim, Ulysses G Gardner, Khadija Sheikh, Junghoon Lee, Ravi Seethamraju, Junichi Tokuda, Chen Hu, Ehud Schmidt, Akila N Viswanathan

Brachytherapy · 2026

DOI: 10.1016/j.brachy.2026.03.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brachytherapy, 2026. Verfasst von Michael Roumeliotis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address…. Hauptthemen laut MEDLINE: Brachytherapy, Genital Neoplasms, Female, Radiotherapy, Image-Guided, Magnetic Resonance Imaging, Interventional. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Elekta, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the feasibility, safety, and workflow of the development and prospective implementation of magnetic resonance-guided position-location tracking technology (MR-tracking [MRT]) for interstitial gynecologic brachytherapy. METHODS AND MATERIALS: Between 2018 and 2023, patients undergoing template-based (Syed/Neblett) interstitial brachytherapy were included in the analysis. The 2 cohorts for analysis were (1) prospectively enrolled patients who received MRT for real-time visualization, and (2) standard procedure implants performed without MRT technology. The 2 cohorts were compared for overall procedural time with an ad hoc inferiority analysis, and implant quality was assessed by the resultant clinically delivered dosimetry with a Student's t test. RESULTS: Eighteen (18) patients who consented to treatment with MRT visualization were compared to a cohort of 62 patients undergoing standard interstitial brachytherapy. The MRT system was successfully used without interruption from device-related events in all 18 patients. The mean (standard deviation) procedure time was 96 (±27) min and 100 (±26) min for the MRT and standard implants, supporting the noninferiority conclusion of the MRT implants (p = 0.03). For the patient subgroup including primary vaginal or recurrent endometrial without a uterus, we reported significantly improved clinical target volume (CTV) coverage (p = 0.02) for the MRT cohort, (CTV D90 = 75.2 Gy) compared to the standard procedure cohort (CTV D90 = 66.4 Gy), suggesting the physician was able to better target the tumor volume during needle insertion. Differences in organ-at-risk doses were not statistically significant. CONCLUSIONS: The prospective study establishes the feasibility of MRT integration with the successful demonstration of device reliability in a complex clinical setting. The integration of MRT as an investigational technology did not negatively impact overall procedure time and may have had a positive effect on resultant dosimetry for a subgroup of patients. Future clinical investigations should include prospective use of the technology in a matched-cohort trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyGenital Neoplasms, FemaleRadiotherapy, Image-GuidedMagnetic Resonance Imaging, InterventionalMagnetic Resonance ImagingHumansFemaleFeasibility StudiesProspective StudiesMiddle AgedWorkflowAgedAdult

Stichwörter der Autor:innen

BrachytherapyFeasibilityGynecologicImage-guidedInterstitialMRIProspectiveSafetyTrackingTrial

Autor:innen und Institutionen

  • Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: mroumel1@jhu.edu.
  • Physics and Advanced Development, Elekta Inc., Washington, DC.
  • Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD.
  • Siemens Healthineers, Boston, MA.
  • Department of Radiology, Brigham and Women's Hospital, Boston, MA.
  • Division of Quantitative Sciences, Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD.

Förderung

  • NCI NIH HHS
  • Elekta
  • National Institutes of Health

Zitieren

APA

Roumeliotis, M., Antaki, M., Kim, G., Gardner, U. G., Sheikh, K., Lee, J., Seethamraju, R., Tokuda, J., Hu, C., Schmidt, E., & Viswanathan, A. N. (2026). Prospective operational feasibility, safety, and workflow of magnetic resonance-guided tracking technology for interstitial gynecologic brachytherapy. Brachytherapy. https://doi.org/10.1016/j.brachy.2026.03.005

Vancouver

Roumeliotis M, Antaki M, Kim G, Gardner UG, Sheikh K, Lee J, et al. Prospective operational feasibility, safety, and workflow of magnetic resonance-guided tracking technology for interstitial gynecologic brachytherapy. Brachytherapy. 2026. doi:10.1016/j.brachy.2026.03.005

BibTeX
@article{Roumeliotis2026,
  author = {Roumeliotis, Michael and Antaki, Majd and Kim, Gayoung and Gardner, Ulysses G and Sheikh, Khadija and Lee, Junghoon and Seethamraju, Ravi and Tokuda, Junichi and Hu, Chen and Schmidt, Ehud and Viswanathan, Akila N},
  title = {Prospective operational feasibility, safety, and workflow of magnetic resonance-guided tracking technology for interstitial gynecologic brachytherapy},
  journal = {Brachytherapy},
  year = {2026},
  doi = {10.1016/j.brachy.2026.03.005}
}
Kostenlos starten →